- Home
- CUBA vs APLT Comparison
CUBA vs APLT Comparison
Compare CUBA & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUBA
- APLT
- Stock Information
- Founded
- CUBA 1992
- APLT 2016
- Country
- CUBA United States
- APLT United States
- Employees
- CUBA N/A
- APLT N/A
- Industry
- CUBA Investment Managers
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- CUBA Finance
- APLT Health Care
- Exchange
- CUBA Nasdaq
- APLT Nasdaq
- Market Cap
- CUBA 41.2M
- APLT 37.5M
- IPO Year
- CUBA N/A
- APLT 2019
- Fundamental
- Price
- CUBA $2.41
- APLT $0.33
- Analyst Decision
- CUBA
- APLT Buy
- Analyst Count
- CUBA 0
- APLT 7
- Target Price
- CUBA N/A
- APLT $6.10
- AVG Volume (30 Days)
- CUBA 93.9K
- APLT 2.3M
- Earning Date
- CUBA 01-01-0001
- APLT 04-14-2025
- Dividend Yield
- CUBA 20.83%
- APLT N/A
- EPS Growth
- CUBA N/A
- APLT N/A
- EPS
- CUBA N/A
- APLT N/A
- Revenue
- CUBA N/A
- APLT $455,000.00
- Revenue This Year
- CUBA N/A
- APLT $3,031.87
- Revenue Next Year
- CUBA N/A
- APLT $312.01
- P/E Ratio
- CUBA N/A
- APLT N/A
- Revenue Growth
- CUBA N/A
- APLT N/A
- 52 Week Low
- CUBA $2.25
- APLT $0.30
- 52 Week High
- CUBA $4.14
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- CUBA 42.56
- APLT 36.05
- Support Level
- CUBA $2.36
- APLT $0.30
- Resistance Level
- CUBA $2.48
- APLT $0.38
- Average True Range (ATR)
- CUBA 0.11
- APLT 0.05
- MACD
- CUBA -0.02
- APLT -0.00
- Stochastic Oscillator
- CUBA 14.71
- APLT 17.19
About CUBA Herzfeld Caribbean Basin Fund Inc. (The)
Herzfeld Caribbean Basin Fund Inc operates as a closed-end management investment company. The company's investment objective is to obtain long-term capital appreciation. The firm offers customized discretionary account management and fund management services to individual and institutional investors. The fund invests in equity and equity-linked securities of public and private companies, including United States-based companies, whose securities are traded principally on a stock exchange in a Caribbean Basin Country. The fund's revenue source is through the dividends it receives. Its investments are geographically allocated in the United States followed by Mexico, Puerto Rico, and other countries.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.